Pili, Roberto – Trademark Portfolio
Entity Type: 01
Pili, Roberto holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SNAC SCIENCES NUTRITION AND CANCER. The owner is based in Buffalo, NY.
37 Middlesex Road
Buffalo, NY 14216
Showing of trademarks Trademarks
Trademark Classifications
Pili, Roberto's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Pili, Roberto have?
Pili, Roberto has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Pili, Roberto file in?
Pili, Roberto files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Pili, Roberto's most well-known trademarks?
Pili, Roberto's registered trademark portfolio includes well-known marks such as SNAC SCIENCES NUTRITION AND CANCER. These are among 2 currently registered trademarks in the portfolio.
What is Pili, Roberto's trademark registration success rate?
Pili, Roberto has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.